A Comprehensive System for Searching and Evaluating Genomic Variant Evidence Using AI and Knowledge Bases to Support Personalized Medicine.

AMIA ... Annual Symposium proceedings. AMIA Symposium Pub Date : 2025-05-22 eCollection Date: 2024-01-01
Jinlian Wang, Hui Li, Hongfang Liu
{"title":"A Comprehensive System for Searching and Evaluating Genomic Variant Evidence Using AI and Knowledge Bases to Support Personalized Medicine.","authors":"Jinlian Wang, Hui Li, Hongfang Liu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We introduce an innovative automated system for the search and assessment of genetic variant evidence, meticulously aligned with ACMG guidelines. Leveraging the synergistic power of artificial intelligence (AI), elastic search, and an extensive knowledge base, our system advances the efficiency and accuracy of genetic variant interpretation. Distinct from existing methodologies, it features a pioneering literature filtering mechanism that automates the identification and relevance ranking of scientific articles, significantly reducing the time spending on literature evidence search and optimizing the evidence assessment process. Implemented and rigorously tested by a commercial company hereditary cancer variant curation team, the system demonstrated its effectiveness and scalability by processing over 3 million PMIDs and 1.8 million full-text articles. Throughout the period of active utilization, significant insights were gleaned into the real-world impact and user experience of the system, conclusively affirming its robustness. Our comparative analysis with Mastermind 2.0 highlights the system's enhanced performance in minimizing false positives for various mutation types. The core AI model exhibits exceptional precision, recall, and F1 scores above 0.8, signifying its adeptness in selecting pertinent literature for variant classification. The experience and knowledge acquired from deploying the system in a commercial setting provide a distinctive outlook on its practicality and prospects for future development. The novel integration of AI with traditional genetic variant curation processes heralds a new era in the field, promising significant advancements and broader application prospects.</p>","PeriodicalId":72180,"journal":{"name":"AMIA ... Annual Symposium proceedings. AMIA Symposium","volume":"2024 ","pages":"1206-1214"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099401/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMIA ... Annual Symposium proceedings. AMIA Symposium","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We introduce an innovative automated system for the search and assessment of genetic variant evidence, meticulously aligned with ACMG guidelines. Leveraging the synergistic power of artificial intelligence (AI), elastic search, and an extensive knowledge base, our system advances the efficiency and accuracy of genetic variant interpretation. Distinct from existing methodologies, it features a pioneering literature filtering mechanism that automates the identification and relevance ranking of scientific articles, significantly reducing the time spending on literature evidence search and optimizing the evidence assessment process. Implemented and rigorously tested by a commercial company hereditary cancer variant curation team, the system demonstrated its effectiveness and scalability by processing over 3 million PMIDs and 1.8 million full-text articles. Throughout the period of active utilization, significant insights were gleaned into the real-world impact and user experience of the system, conclusively affirming its robustness. Our comparative analysis with Mastermind 2.0 highlights the system's enhanced performance in minimizing false positives for various mutation types. The core AI model exhibits exceptional precision, recall, and F1 scores above 0.8, signifying its adeptness in selecting pertinent literature for variant classification. The experience and knowledge acquired from deploying the system in a commercial setting provide a distinctive outlook on its practicality and prospects for future development. The novel integration of AI with traditional genetic variant curation processes heralds a new era in the field, promising significant advancements and broader application prospects.

利用人工智能和知识库搜索和评估基因组变异证据的综合系统以支持个性化医疗。
我们引进了一种创新的自动化系统,用于搜索和评估遗传变异证据,精心配合ACMG指南。利用人工智能(AI)的协同力量,弹性搜索和广泛的知识库,我们的系统提高了遗传变异解释的效率和准确性。与现有方法不同,它具有开创性的文献过滤机制,可自动识别科学文章并对其进行相关性排序,大大减少了文献证据检索的时间,优化了证据评估过程。该系统由一家商业公司的遗传癌症变异管理团队实施并进行了严格的测试,通过处理超过300万份pmid和180万篇全文文章,证明了其有效性和可扩展性。在整个积极使用期间,收集了关于系统的实际影响和用户体验的重要见解,最终肯定了它的健壮性。我们与Mastermind 2.0的比较分析突出了系统在减少各种突变类型的误报方面的增强性能。核心AI模型表现出优异的准确率、召回率,F1得分在0.8以上,表明它能够熟练地选择相关文献进行变量分类。在商业环境中部署该系统所获得的经验和知识为其实用性和未来发展前景提供了独特的前景。人工智能与传统基因变异策展过程的全新融合预示着该领域的新时代,有望取得重大进展和更广阔的应用前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信